Rhiannon Price, Pharmacist at King Edward Memorial Hospital.[/caption]
Caspar Townsend MPS, Pharmacist at Perth Children's Hospital compounding unit[/caption]
Iraq Doali, NSW-based locum pharmacist and content creator[/caption]
Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Are you up to speed on COVID-19 antiviral eligibility changes?
On 11 July, millions of Australians gained access to oral COVID-19 antiviral treatments after the eligibility criteria widened significantly.
UTI pilot decision a step forward in pharmacy prescribing
Queensland pharmacies that took part in the 2-year Urinary Tract Infection Pharmacy Pilot – Queensland can continue indefinitely.
Paracetamol restrictions: balancing risk with access
Pharmacist intervention can ensure paracetamol is used safely and effectively without restricting access to millions of Australians.
Off-label use of medicines
By understanding the risks involved in the supply of off-label medicines, pharmacists can best fulfil their professional responsibilities.
N-acetylcysteine for methamphetamine dependence
NAC has the potential to be a much-needed and affordable pharmacological option for harm minimisation related to not only methamphetamine dependence, but also of...
AstraZeneca COVID-19 vaccine and clotting: what to watch for
An expert panel has confirmed a second case of thrombosis with thrombocytopenia in Australia is likely linked to AstraZeneca’s COVID-19 vaccine.
